These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3150503)

  • 21. [Immunologic characteristics of the purified and concentrated anatoxins of Cl. histolyticum].
    Vlasova EV; Shamraeva SS; Shemanova GF; Borisova OK
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Jul; 45(7):135-9. PubMed ID: 5731533
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tetanus immunization].
    Hansen F
    Landarzt; 1967 May; 43(15):694-8. PubMed ID: 5612016
    [No Abstract]   [Full Text] [Related]  

  • 23. [Problems of the immunoprophylaxis of experimental Pseudomonas pyocyanea wound sepsis].
    Kolker II; Stanislavskiĭ ES; Grishina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):67-72. PubMed ID: 110018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of anaerobic corynebacterial immunostimulants on the primary immune response to tetanus toxoid and Perfringens epsilon toxoid. (Short communication).
    Gelencsér F; Réthy L; Bácskai L; Géresi M; Pogány I; Padányi M; Réthy LA
    Acta Vet Acad Sci Hung; 1981; 28(3):285-7. PubMed ID: 6266236
    [No Abstract]   [Full Text] [Related]  

  • 25. [The isolation of tetanolysin and study of its protective activity].
    Postanogova GV; Efimova NP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):48-51. PubMed ID: 1867035
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction in animal usage for potency testing of diphtheria and tetanus toxoids.
    Stainer DW; Jakus CM; Sparkes JD
    Dev Biol Stand; 1986; 65():241-4. PubMed ID: 3556773
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pseudomonas aeruginosa toxoid].
    Ianishevskaia MN
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):27-32. PubMed ID: 3922181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial action of complexing compounds. II. Influence of disodium ethylendiaminetetraacetate (NA2EDTA) on experimental infection with Pseudomonas aeruginosa in mice.
    Rogala D; Kapp-Burzyńska Z; Komider S
    Arch Immunol Ther Exp (Warsz); 1974; 22(6):791-6. PubMed ID: 4217611
    [No Abstract]   [Full Text] [Related]  

  • 29. Tetanus prophylaxis for diabetic foot ulcers.
    Rogers LC; Frykberg RG
    Clin Podiatr Med Surg; 2006 Oct; 23(4):769-75, vii-i. PubMed ID: 17067894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunoprophylaxis and immunotherapy of infection caused by Pseudomonas aeruginosa: research results and prospects].
    Stanislavskiĭ ES; Joó I
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):22-31. PubMed ID: 6414198
    [No Abstract]   [Full Text] [Related]  

  • 31. Prophylactic effect of ornidazole on experimental tetanus in mice.
    Erenmemisoglu A; Tekol Y; Aydin N
    Drugs Exp Clin Res; 1995; 21(2):59-63. PubMed ID: 7555610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria.
    Vrancheva S; Vulchev V; Bachev S
    Prog Immunobiol Stand; 1970; 4():548-52. PubMed ID: 5482199
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine.
    Iwaki M; Komiya T; Fukuda T; Arakawa Y; Takahashi M
    Jpn J Infect Dis; 2003 Aug; 56(4):183-5. PubMed ID: 14583650
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effectiveness of allogeneic and xenogeneic antitoxins in preventing tetanus in an experiment].
    Nazarchuk LV
    Fiziol Zh (1978); 1987; 33(6):83-5. PubMed ID: 3446533
    [No Abstract]   [Full Text] [Related]  

  • 36. Management and prevention of tetanus.
    Edlich RF; Hill LG; Mahler CA; Cox MJ; Becker DG; Horowitz JH; Nichter LS; Martin ML; Lineweaver WC
    J Long Term Eff Med Implants; 2003; 13(3):139-54. PubMed ID: 14516181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of mouse strain on the assayed potency (unitage) of tetanus toxoid.
    Hardegree MC; Pittman M; Maloney CJ
    Appl Microbiol; 1972 Jul; 24(1):120-6. PubMed ID: 5057368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of national standards in the control of standardization of diphtheria and tetanus anatoxins. Conditions of measurement in international units and immunogenic value of tetanus anatoxin for guinea pigs and mice].
    Demian L; Lazăr M
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):297-302. PubMed ID: 5400034
    [No Abstract]   [Full Text] [Related]  

  • 39. Current concepts in the management of Clostridium tetani infection.
    Brook I
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):327-36. PubMed ID: 18588497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice.
    Sokalska M; Maresz-Babczyszyn J
    Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.